|
Chemical
Name:
Chlordiazepoxide HCL Brand
Name:
Librium Manufacturer:
Hoffman-La
Roche, Inc. Description:
A
benzodiazepine compound. The
precise mechanism of action is unknown. Indications
and Use: Indicated
for the management of anxiety disorders or for the short-term relief of the
symptoms of anxiety, withdrawal symptoms of acute alcoholism and preoperative
apprehension and anxiety. Anxiety
or tension associated with everyday life usually does not require treatment with
an anxiolytic. Contraindications,
Warnings and Precautions:
Caution
should be used when driving or in hazardous occupations that require complete
mental alertness. An increased risk of congenital malformation in the first
trimester of pregnancy has been suggested in several studies of this type of
drug. Do not use with alcohol or
other central nervous system depressants. Paradoxical
reactions such as excitement, stimulation and acute rage have been reported in
psychiatric patients and in hyperactive aggressive pediatric patients, and
should be watched for during treatment with Librium. As with other benzodiazepines, caution must be used in
persons known to be addiction-prone or persons whose history suggests likelihood
they might increase the dose on their own initiative. Withdrawal symptoms have occurred following the abrupt
discontinuation of chlordiaxepoxide. Adverse
Reactions:
Possible common side effects may include drowsiness or lethargy. Less
common side effects may include ataxia, confusion, nausea, constipation,
menstrual irregularities and altered libido. Dosing
Range:
Dosage should be individualized according to reason for use and age of
patient. Do not exceed 300mg in a
24 hour period. |
|
These pages are solely for public informational purposes. The information cannot be relied on to make diagnoses or prescribe treatment in any individual. Persons who require such services should consult with a licensed professional. Send mail to ropa@redoakpsychiatry.com with questions or comments about this web site.© 2000 Red Oak Psychiatry Associates, P.A. Updated
11/26/2007
|